FDA Seeks Input on Drug Repurposing for Unmet Medical Needs
FDA is establishing a public docket for drug repurposing input.
Drug profile · INN
APO-INDAPAMIDE SR
indapamide (APO-INDAPAMIDE SR) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
indapamide (APO-INDAPAMIDE SR) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Thiazide-sensitive sodium-chloride cotransporter inhibitor
Primary target: Solute carrier family 12 member 3
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
indapamide (APO-INDAPAMIDE SR) is a thiazide-sensitive sodium-chloride cotransporter inhibitor. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
APO-INDAPAMIDE SR is a marketed brand name for indapamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
indapamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.